rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BWAY
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      BrainsWay: 3 Key Takeaways for Long-Term Investors
      Nov 11Yahoo FinanceBWAY
      BrainsWay Ltd (BRSYF) (Q3 2026) Earnings Call Highlights: Revenue Jumps 34% as Margins Expand ...

      BrainsWay Ltd (BRSYF) posted $18.1 million in Q3 2026 revenue, doubled operating income to $2.6 million, and signaled full-year results at the high end of guidance on strong SWIFT and OCD demand.

      Nov 10Yahoo FinanceBWAY
      What Brainsway (BWAY) Said on Its Q3 Earnings Call
      Nov 10Yahoo FinanceBWAY
      BrainsWay Q3 2026 Earnings Call Transcript
      Nov 10BenzingaBWAY
      Brainsway earnings missed by $0.04, revenue topped estimates
      Nov 10Investing.comBWAY
      BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights

      Revenue increased 34% to $18.1 million in Q3 2026; Operating income rose 107% to $2.6 million and Adjusted EBITDA rose approximately 92% to $3.9 million Remaining performance obligations grew 31% year-over-year to approximately $85 million Shipped 130 Deep TMS systems in Q3 2026, a 44% increase year-over-year Full-year 2026 revenue, operating income margin and Adjusted EBITDA expected at the upper end of guidance with potential to modestly exceed it BURLINGTON, Mass. and JERUSALEM, Nov. 10, 2026

      Nov 10Yahoo FinanceBWAY
      Earnings To Watch: BrainsWay Ltd (BWAY) Q3 2026 -- GF Value Sees 20% Downside
      Nov 9Yahoo FinanceBWAY
      H.C. Wainwright reiterates Brainsway stock rating on strategic collaboration
      Nov 3Investing.comBWAY
      BrainsWay Partners With Mindful Health Solutions to Expand Access to TMS Treatments
      Nov 2Yahoo FinanceBWAY
      BrainsWay partners with Mindful Health Solutions network
      Nov 2Investing.comBWAY
      BrainsWay Announces Strategic Collaboration with Mindful Health Solutions
      Nov 2Yahoo FinanceBWAY
      Brainsway stock price target maintained at $19 by H.C. Wainwright
      Oct 30Investing.comBWAY
      BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026
      Oct 28Yahoo FinanceBWAY
      BrainsWay expands insurance coverage for OCD treatment to 118M
      Oct 26Investing.comBWAY
      Brainsway Increases Insurance Companies Covering its OCD Treatment
      Oct 26Yahoo FinanceBWAY
      BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
      Oct 26Yahoo FinanceBWAY
      BrainsWay Sets November 25, 2026 Annual Shareholder Meeting With Auditor, Board and Equity Votes

      Detailed price information for Brainsway Ltd ADR (BWAY-Q) from The Globe and Mail including charting and trades.

      Oct 22The Globe and MailBWAY
      Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cullinan Management (CGEM) and BeOne Medicines (ONC)

      Detailed price information for Brainsway Ltd ADR (BWAY-Q) from The Globe and Mail including charting and trades.

      Oct 21The Globe and MailBWAYONC
      H.C. Wainwright reiterates Brainsway stock rating on IPMG deal
      Oct 20Investing.comBWAY
      BrainsWay to Supply Deep TMS Systems to Southern California Psychiatric Group
      Oct 19Yahoo FinanceBWAY
      BrainsWay partners with California psychiatric group
      Oct 19Investing.comBWAY
      BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
      Oct 19Yahoo FinanceBWAY
      BrainsWay Expands U.S. Coverage for SWIFT Deep TMS to Over 70 Million Lives

      Detailed price information for Brainsway Ltd ADR (BWAY-Q) from The Globe and Mail including charting and trades.

      Oct 14The Globe and MailBWAY
      BrainsWay expands U.S. insurance coverage to 70 million lives
      Oct 13Investing.comBWAY
      BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
      Oct 13Yahoo FinanceBWAY
      BrainsWay: Execution Isn’t The Problem, Market Size Is (NASDAQ:BWAY)
      Sep 22Seeking AlphaBWAY
      Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)

      Detailed price information for Cooper Companies (COO-Q) from The Globe and Mail including charting and trades.

      Sep 11The Globe and MailBWAYRCUS
      BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore

      On August 12, BrainsWay Ltd. (NASDAQ:BWAY) reported second-quarter 2026 results that make the neurostimulation company look less like a niche medtech story and more like a genuine growth compounder. Revenue climbed 35% year over year to a record $17.1 million, and adjusted EBITDA more than doubled to $3.5 million. The company shipped 125 Deep TMS […]

      Sep 11Yahoo FinanceBWAY
      Are Options Traders Betting on a Big Move in Brainsway Stock?

      Investors need to pay close attention to BWAY stock based on the movements in the options market lately.

      Sep 9Yahoo FinanceBWAY
      Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), Ionis Pharmaceuticals (IONS) and Brainsway (BWAY)

      Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.

      Sep 9The Globe and MailBWAY
      BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
      Sep 8Yahoo FinanceBWAY
      H.C. Wainwright raises Brainsway stock price target on new data
      Aug 31Investing.comBWAY
      Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High?

      The mean of analysts' price targets for Brainsway (BWAY) points to a 30.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

      Aug 27Yahoo FinanceBWAY
      BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation

      Peer-reviewed secondary analysis adds to growing body of clinical evidence supporting the potential role of Deep TMS in addressing suicidal ideation among patients with major depressive disorderBURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of new peer-reviewed data demonstrating significant reductions in suicid

      Aug 27Yahoo FinanceBWAY

      This is the newest page. Registered accounts read further back.